Philippe Picaut

1.3k total citations
48 papers, 863 citations indexed

About

Philippe Picaut is a scholar working on Neurology, Rehabilitation and Psychiatry and Mental health. According to data from OpenAlex, Philippe Picaut has authored 48 papers receiving a total of 863 indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Neurology, 21 papers in Rehabilitation and 19 papers in Psychiatry and Mental health. Recurrent topics in Philippe Picaut's work include Botulinum Toxin and Related Neurological Disorders (44 papers), Stroke Rehabilitation and Recovery (21 papers) and Cerebral Palsy and Movement Disorders (19 papers). Philippe Picaut is often cited by papers focused on Botulinum Toxin and Related Neurological Disorders (44 papers), Stroke Rehabilitation and Recovery (21 papers) and Cerebral Palsy and Movement Disorders (19 papers). Philippe Picaut collaborates with scholars based in France, United States and Poland. Philippe Picaut's co-authors include Keith Foster, Claire Vilain, Jan P. Langenberg, Daan Noort, Mauricio R. Delgado, Anne‐Sophie Grandoulier, Magali Volteau, Allison Brashear, Jean‐Michel Graciès and Marta Banach and has published in prestigious journals such as Neurology, PEDIATRICS and The Lancet Neurology.

In The Last Decade

Philippe Picaut

48 papers receiving 837 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Philippe Picaut France	18	746	248	202	193	146	48	863
Benjamin Zakine France	9	522 0.7×	138 0.6×	163 0.8×	145 0.8×	102 0.7×	10	587
Fereshte Adib Saberi Germany	13	655 0.9×	76 0.3×	45 0.2×	235 1.2×	189 1.3×	28	786
Amanda M. VanDenburgh United States	16	381 0.5×	413 1.7×	99 0.5×	72 0.4×	287 2.0×	21	1.5k
Susanne Grafe Germany	12	1.1k 1.4×	66 0.3×	98 0.5×	463 2.4×	207 1.4×	18	1.1k
Carl‐Albrecht Haensch Germany	12	235 0.3×	122 0.5×	16 0.1×	52 0.3×	71 0.5×	39	617
Gottfried Kranz Austria	11	268 0.4×	27 0.1×	20 0.1×	84 0.4×	140 1.0×	28	440
Francesca Bianchi Italy	15	260 0.3×	45 0.2×	15 0.1×	143 0.7×	85 0.6×	32	590
Liron S. Duraku Netherlands	14	65 0.1×	38 0.2×	91 0.5×	146 0.8×	204 1.4×	75	596
Wolfgang Hamann United Kingdom	15	66 0.1×	33 0.1×	41 0.2×	83 0.4×	299 2.0×	33	766
S. Veronica Tan United Kingdom	18	254 0.3×	88 0.4×	16 0.1×	503 2.6×	60 0.4×	41	956

Countries citing papers authored by Philippe Picaut

Since Specialization

Citations

This map shows the geographic impact of Philippe Picaut's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philippe Picaut with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philippe Picaut more than expected).

Fields of papers citing papers by Philippe Picaut

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philippe Picaut. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philippe Picaut. The network helps show where Philippe Picaut may publish in the future.

Co-authorship network of co-authors of Philippe Picaut

This figure shows the co-authorship network connecting the top 25 collaborators of Philippe Picaut. A scholar is included among the top collaborators of Philippe Picaut based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philippe Picaut. Philippe Picaut is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ascher, Benjamin, Philippe Kestemont, Alessio Redaelli, et al.. (2023). International Consensus Recommendations on the Aesthetic Usage of Ready-to-Use AbobotulinumtoxinA (Alluzience). Aesthetic Surgery Journal. 44(2). 192–202. 5 indexed citations

Wu, Yan, Fang Fang, Lai Wei, et al.. (2022). Efficacy and Safety of AbobotulinumtoxinA for the Treatment of Glabellar Lines in Chinese Patients: A Pivotal, Phase 3, Randomized, Double-Blind and Open-Label Phase Study. Aesthetic Plastic Surgery. 47(1). 351–364. 7 indexed citations

Lejeune, Thierry, Svetlana Khatkova, Lynne Turner‐Stokes, et al.. (2020). Abobotulinumtoxina injections in shoulder muscles to improve adult upper limb spasticity: Results from a phase 4 real-world study and a phase 3 open-label trial. Journal of Rehabilitation Medicine. 52(6). jrm00068–jrm00068. 5 indexed citations

McAllister, Peter J., et al.. (2019). Effects on walking of simultaneous upper/lower limb abobotulinumtoxina injections in patients with stroke or brain injury with spastic hemiparesis. Journal of Rehabilitation Medicine. 51(10). 813–816. 5 indexed citations

Pons, Laurent, Claire Vilain, Magali Volteau, & Philippe Picaut. (2019). Safety and pharmacodynamics of a novel recombinant botulinum toxin E (rBoNT-E): Results of a phase 1 study in healthy male subjects compared with abobotulinumtoxinA (Dysport®). Journal of the Neurological Sciences. 407. 116516–116516. 23 indexed citations

Dursun, Nigar, Marcin Bonikowski, Edward Dabrowski, et al.. (2019). Efficacy of Repeat AbobotulinumtoxinA (Dysport®) Injections in Improving Gait in Children with Spastic Cerebral Palsy. Developmental Neurorehabilitation. 23(6). 368–374. 11 indexed citations

Ascher, Benjamin, Berthold Rzany, Philippe Kestemont, et al.. (2019). Significantly Increased Patient Satisfaction Following Liquid Formulation AbobotulinumtoxinA Treatment in Glabellar Lines: FACE-Q Outcomes From a Phase 3 Clinical Trial. Aesthetic Surgery Journal. 40(9). 1000–1008. 18 indexed citations

Dabrowski, Edward, Marcin Bonikowski, Mark Gormley, et al.. (2018). AbobotulinumtoxinA Efficacy and Safety in Children With Equinus Foot Previously Treated With Botulinum Toxin. Pediatric Neurology. 82. 44–49. 4 indexed citations

Isner-Horobeti, Marie-Ève, Jean‐Michel Graciès, Allison Brashear, et al.. (2017). Duration of effect of abobotulinumtoxinA (Dysport®) in adult patients with lower limb spasticity post-stroke or traumatic brain injury. Annals of Physical and Rehabilitation Medicine. 60. e26–e27. 1 indexed citations

10.

Marqué, P., Jean‐Michel Graciès, Allison Brashear, et al.. (2017). Duration of effect of abobotulinumtoxinA (Dysport®) in adult patients with upper limb spasticity (ULS) post-stroke or traumatic brain injury. Annals of Physical and Rehabilitation Medicine. 60. e24–e25. 1 indexed citations

11.

O’Dell, Michael W., Allison Brashear, Robert Jech, et al.. (2017). Dose‐Dependent Effects of AbobotulinumtoxinA (Dysport) on Spasticity and Active Movements in Adults With Upper Limb Spasticity: Secondary Analysis of a Phase 3 Study. PM&R. 10(1). 1–10. 12 indexed citations

12.

Delgado, Mauricio R., Marcin Bonikowski, Edward Dabrowski, et al.. (2017). Safety and Efficacy of Repeat Open-Label AbobotulinumtoxinA Treatment in Pediatric Cerebral Palsy. Journal of Child Neurology. 32(13). 1058–1064. 25 indexed citations

13.

Matthews, Dennis J., Samuel Ignacio Pascual Pascual, Ann Tilton, et al.. (2016). Poster 485 Safety and Tolerability of AbobotulinumtoxinA (Dysport) in Children (2‐17 Years) with Lower Limb Spasticity Due to Cerebral Palsy: A Pooled Analysis of 8 Clinical Trials. PM&R. 8(9S). S318–S318. 2 indexed citations

14.

Tilton, Ann, Edward Dabrowski, Dennis J. Matthews, et al.. (2016). Quantitative Effects of Botulinum Toxin Treatment on the Modified Ashworth Scale and the Tardieu Scale: Results from a Randomized Controlled Study of AbobotulinumtoxinA in Children with Dynamic Equinus Foot Deformity due to Cerebral Palsy (S10.006). Neurology. 86(16_supplement). 1 indexed citations

15.

Graciès, Jean‐Michel, Alberto Esquenazi, Allison Brashear, et al.. (2016). Poster 288 Efficacy and Safety of Repeated AbobotulinumtoxinA Injections in Adults with Lower Limb Spasticity. PM&R. 8(9S). S254–S254. 1 indexed citations

16.

Poewe, Werner, Pierre Burbaud, Giovanni Castelnovo, et al.. (2016). Efficacy and safety of abobotulinumtoxinA liquid formulation in cervical dystonia: A randomized‐controlled trial. Movement Disorders. 31(11). 1649–1657. 31 indexed citations

17.

Graciès, Jean‐Michel, Allison Brashear, Robert Jech, et al.. (2015). Safety and efficacy of abobotulinumtoxinA for hemiparesis in adults with upper limb spasticity after stroke or traumatic brain injury: a double-blind randomised controlled trial. The Lancet Neurology. 14(10). 992–1001. 147 indexed citations

18.

Hauser, Robert A., et al.. (2012). AbobotulinumtoxinA (Dysport) dosing in cervical dystonia: an exploratory analysis of two large open-label extension studies. Journal of Neural Transmission. 120(2). 299–307. 19 indexed citations

19.

Hubble, Jean, et al.. (2012). Immunoresistance in Cervical Dystonia Patients After Treatment With AbobotulinumtoxinA. International Journal of Neuroscience. 122(7). 358–362. 13 indexed citations

20.

Behr‐Roussel, Delphine, S. Oger, Bernadette Pignol, et al.. (2012). Minimal Effective Dose of Dysport and Botox in a Rat Model of Neurogenic Detrusor Overactivity. European Urology. 61(5). 1054–1061. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact